Effect of substituted benzamides on feeding and hypothalamic neuropeptide Y-like immunoreactivity (NPY-LI) in rats

The study was conducted: (i) to evaluate the effects of three substituted benzamides on feeding behaviour in rats with free access to food and in those with access to food limited either to the light or to the dark phase of the diurnal cycle; and (ii) to determine whether the hypothalamic neuropeptide Y (NPY) system is involved in the action of these drugs on feeding. In free-feeding rats, a single dose of eticlopride (1 mg/kg, i.p.) or raclopride (1 mg/kg, i.p.) decreased 24-h food intake, whereas remoxipride (3 mg/kg, i.p.) produced no effect. Single doses of eticlopride and raclopride but not of remoxipride decreased hypothalamic neuropeptide Y-like immunoreactivity (NPY-LI). Eticlopride administered once daily for 14 days decreased both food intake and hypothalamic NPY-LI. When given for 14 days, raclopride and remoxipride decreased food intake in rats with access to food in the dark (19.00-07.00) but not in thelight (07.00-19.00) phase of the diurnal cycle; both these compounds decreased hypothalamic NPY-LI only in the former group of rats. The results suggest that the effects of substituted benzamides on feeding behaviour depend on the drug and the time of administration and that these effects are related to the altered function of the hypothalamic NPY system.

[1]  W. Langhans,et al.  New approaches in the pharmacological treatment of obesity , 1999, European journal of nutrition.

[2]  P S Kalra,et al.  Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. , 1999, Endocrine reviews.

[3]  K. Shieh,et al.  Ontogeny of the Diurnal Rhythm of Tuberoinfundibular Dopaminergic Neuronal Activity in Peripubertal Female Rats: Possible Involvement of Cholinergic and Opioidergic Systems , 1998, Neuroendocrinology.

[4]  I. Zimanyi,et al.  Central control of feeding behavior by neuropeptide Y. , 1998, Current pharmaceutical design.

[5]  S. Dryden,et al.  Differential effects of the 5-HT 1B 2C receptor agonist mCPP and the 5-HT1A agonist flesinoxan on hypothalamic neuropeptide Y in the rat: Evidence that NPY may mediate serotonin's effects on food intake , 1996, Peptides.

[6]  E. Obuchowicz.  Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus , 1996, Neuropeptides.

[7]  S. Dryden,et al.  The serotonergic agent fluoxetine reduces neuropeptide y levels and neuropeptide y secretion in the hypothalamus of lean and obese rats , 1996, Neuroscience.

[8]  S. Leibowitz,et al.  Hypothalamic Neuropeptide Y and Its Gene Expression: Relation to Light/Dark Cycle and Circulating Corticosterone , 1994, Molecular and Cellular Neuroscience.

[9]  M. G. Dube,et al.  Evidence that neuropeptide Y is a physiological signal for normal food intake , 1994, Brain Research.

[10]  B. Stanley,et al.  Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake , 1993, Brain Research.

[11]  J. Simard,et al.  Dopaminergic regulation of pre-proNPY mRNA levels in the rat arcuate nucleus , 1991, Neuroscience Letters.

[12]  B. Hoebel,et al.  Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats , 1988, Pharmacology Biochemistry and Behavior.

[13]  V. Hillegaart,et al.  Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behaviour and catalepsy in rats: behavioural profile comparisons between raclopride, haloperidol and preclamol. , 1987, Pharmacology & toxicology.

[14]  G. Pelletier,et al.  The role of dopamine in the control of neuropeptide Y neurons in the rat arcuate nucleus , 1986, Neuroscience Letters.

[15]  T. O'donohue,et al.  Amphetamine-induced changes in immunoreactive NPY in rat brain, pineal gland and plasma , 1985, Peptides.

[16]  N. Zisapel,et al.  Circadian variations in the inhibition of dopamine release from adult and newborn rat hypothalamus by melatonin. , 1985, Neuroendocrinology.

[17]  M. Aldegunde,et al.  Variations in monoamine contents in discrete brain regions and their concomitance with plasma corticosteroids during the day. , 1984, The International journal of neuroscience.

[18]  P. Jenner,et al.  Multiple Dopamine Receptors in Brain and the Pharmacological Action of Substituted Benzamide Drugs , 1984, Acta psychiatrica Scandinavica. Supplementum.

[19]  E. Rouer,et al.  Effect of 6-hydroxydopamine on daily variations of 5-HT synthesis in the hypothalamus of the rat. , 1973, Brain research.

[20]  G. Skuza,et al.  Neuropsychopharmacological profile of remoxipride in comparison with clozapine. , 1997, Polish journal of pharmacology.

[21]  M. Heilig,et al.  Neurobiology and clinical aspects of neuropeptide Y. , 1995, Critical reviews in neurobiology.

[22]  C. Wahlestedt,et al.  Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. , 1994, Brain research. Molecular brain research.

[23]  T. Högberg.  The development of dopamine D2-receptor selective antagonists. , 1993, Drug design and discovery.

[24]  G. Williams,et al.  Increased neuropeptide Y concentrations in the lateral hypothalamic area of the rat after the onset of darkness: possible relevance to the circadian periodicity of feeding behavior. , 1991, Life sciences.

[25]  R. Coulombe,et al.  Diurnal alterations of catecholamines, indoleamines and their metabolites in specific brain regions of the mouse. , 1989, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

[26]  Joachim F. R. König,et al.  The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem , 1986 .

[27]  J. Martin,et al.  Diurnal variation in hypothalamic monoamines and plasma corticosterone in the turkey after inhibition of tyrosine hydroxylase or tryptophan hydroxylase. , 1982, Neuroendocrinology.